CopyMark Law Group
4.9/5
Drawing for GOOD LIFE

USPTO serial 50091700

GOOD LIFE

Reviewed by CopyMark Law Group

Status 630
Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with GOOD LIFE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

SHANNON MARIE MCKEON

SHANNON MARIE MCKEON DYKEMA GOSSETT PLLC1301 K Street, N.W., Suite 1100Washington, DC 20005United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; prescription medications for weight management, weight loss and the maintenance of weight loss; compounded medications for weight management, weight loss and the maintenance of weight loss; pharmaceutical preparations for the treatment of sexual dysfunction and erectile dysfunction; pharmaceutical preparations for the treatment of hair loss; peptide-based pharmaceutical preparations for the treatment of growth hormone deficiency; peptide-based pharmaceutical preparations for stimulating endogenous growth hormone production; pharmaceutical preparations for reducing oxidative stressACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 4, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 4, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance